Clinical Trial Update: Phase IV:Safety and Efficacy of EMSAM in Adolescents With Major Depression [Phase 4]

View source ↗

Summary

Phase IV trial update evaluating EMSAM (selegiline transdermal system) for safety and efficacy in adolescents with major depressive disorder; results have been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• EMSAM (selegiline)

Snippet

Sponsor: Somerset Pharmaceuticals | Conditions: Major Depressive Disorder | Phase 4 | Status: COMPLETED | Results posted: 2013-06-26